Ameritas Advisory Services’s VanEck Biotech ETF BBH Stock Holding History

Ameritas Advisory Services’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$75.4K	Buy	+371	New	+$69.8K	﹤0.01%	1200
2025 Q4	–	Sell	-150	Closed	-$24.9K	–	1019
2025 Q3	$24.9K	Sell	150 -221	-60%	-$36K	﹤0.01%	1367
2025 Q2	$56.9K	Buy	+371	New	+$55.3K	﹤0.01%	1245
2023 Q2	–	Sell	-371	Closed	-$60.6K	–	708
2023 Q1	$60.6K	Buy	+371	New	+$60K	﹤0.01%	1196

Other funds holding BBH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.09B AUM 18.31% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

CCA

Conservest Capital Advisors Wynnewood, Pennsylvania $1.26B AUM 24.75% 1-Year Est. Return

BFG

Bleakley Financial Group Fairfield, New Jersey $7.85B AUM 31.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Ameritas Advisory Services's BBH Position: Q2 2026 in Review

Ameritas Advisory Services opened a new position in VanEck Biotech ETF (BBH) in Q2 2026: 371 shares worth $75.4K. The stake represents ﹤0.01% of the portfolio and ranks #1200 among its holdings. This is a return to the name: Ameritas Advisory Services previously reported a position in BBH as recently as Q3 2025.

Ameritas Advisory Services first reported a position in BBH in Q1 2023 and has held it in 4 quarters since. 110 funds tracked by Wall St. Rank hold BBH as of Q2 2026.

Ameritas Advisory Services held 371 shares of VanEck Biotech ETF worth $75.4K as of Q2 2026.
VanEck Biotech ETF was a new Ameritas Advisory Services position in Q2 2026.
VanEck Biotech ETF made up ﹤0.01% of Ameritas Advisory Services's portfolio in Q2 2026, its #1200 holding.
Ameritas Advisory Services first reported a position in VanEck Biotech ETF in Q1 2023 and has held it in 4 quarters since.
110 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2026.

Based on Ameritas Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.